<DOC>
	<DOCNO>NCT01547299</DOCNO>
	<brief_summary>The purpose study determine enzalutamide effective therapy treat localized prostate cancer prior prostatectomy .</brief_summary>
	<brief_title>Study Enzalutamide ( Formerly MDV3100 ) Neoadjuvant Therapy Patients Undergoing Prostatectomy Localized Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Dutasteride</mesh_term>
	<criteria>Willing provide inform consent 18 year age old Histologically confirm adenocarcinoma prostate Must candidate radical prostatectomy consider surgically resectable Stage T4 prostate cancer clinical radiologic evaluation Treatment investigational agent within 4 week prior randomization Received therapy neoplastic disorder within 5 year Hypogonadism severe androgen deficiency</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>prostatectomy</keyword>
	<keyword>neoadjuvant</keyword>
</DOC>